These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 19125051)
1. Optimizing safety of selective internal radiation therapy (SIRT) of hepatic tumors with 90Y resin microspheres: a systematic approach to preparation and radiometric procedures. Schleipman AR; Gallagher PW; Gerbaudo VH Health Phys; 2009 Feb; 96(2 Suppl):S16-21. PubMed ID: 19125051 [TBL] [Abstract][Full Text] [Related]
2. Resin 90Y microsphere activity measurements for liver brachytherapy. Dezarn WA; Kennedy AS Med Phys; 2007 Jun; 34(6):1896-900. PubMed ID: 17654890 [TBL] [Abstract][Full Text] [Related]
3. Residual activity after radioembolization of liver tumours with 90Y resin microspheres. A safe calculation method. Ahmadzadehfar H; Haslerud T; Reichmann K; Meyer C; Habibi E; Fimmers R; Muckle M; Sabet A; Biersack HJ; Ezziddin S Nuklearmedizin; 2014; 53(3):95-8. PubMed ID: 24105253 [TBL] [Abstract][Full Text] [Related]
4. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Welsh JS; Kennedy AS; Thomadsen B Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S62-73. PubMed ID: 16979443 [TBL] [Abstract][Full Text] [Related]
5. Quality assurance issues for therapeutic application of radioactive microspheres. Dezarn WA Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S147-51. PubMed ID: 18406915 [TBL] [Abstract][Full Text] [Related]
6. Selective internal radiation therapy: 90Y (yttrium) labeled microspheres for liver malignancies (primary and metastatic). Uthappa MC; Ravikumar R; Gupta A Indian J Cancer; 2011; 48(1):18-23. PubMed ID: 21330750 [TBL] [Abstract][Full Text] [Related]
7. Internal radiation therapy for patients with primary or metastatic hepatic cancer: a review. Ho S; Lau WY; Leung TW; Johnson PJ Cancer; 1998 Nov; 83(9):1894-907. PubMed ID: 9806647 [TBL] [Abstract][Full Text] [Related]
8. Development of activity standard for 90 Y microspheres. Mo L; Avci B; James D; Simpson B; Van Wyngaardt WM; Cessna JT; Baldock C; Appl Radiat Isot; 2005 Aug; 63(2):193-9. PubMed ID: 15963429 [TBL] [Abstract][Full Text] [Related]
9. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Kennedy AS; Coldwell D; Nutting C; Murthy R; Wertman DE; Loehr SP; Overton C; Meranze S; Niedzwiecki J; Sailer S Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):412-25. PubMed ID: 16690429 [TBL] [Abstract][Full Text] [Related]
10. Radiation microsphere-induced GI ulcers after selective internal radiation therapy for hepatic tumors: an underrecognized clinical entity. Konda A; Savin MA; Cappell MS; Duffy MC Gastrointest Endosc; 2009 Sep; 70(3):561-7. PubMed ID: 19577743 [TBL] [Abstract][Full Text] [Related]
11. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Kennedy A; Nag S; Salem R; Murthy R; McEwan AJ; Nutting C; Benson A; Espat J; Bilbao JI; Sharma RA; Thomas JP; Coldwell D Int J Radiat Oncol Biol Phys; 2007 May; 68(1):13-23. PubMed ID: 17448867 [TBL] [Abstract][Full Text] [Related]
12. Radioassay of yttrium-90 radiation using the radionuclide dose calibrator. Salako QA; DeNardo SJ J Nucl Med; 1997 May; 38(5):723-6. PubMed ID: 9170436 [TBL] [Abstract][Full Text] [Related]
13. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer. Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513 [TBL] [Abstract][Full Text] [Related]
14. Selective internal radiation therapy-induced extrahepatic injury: an emerging cause of iatrogenic organ damage. Crowder CD; Grabowski C; Inampudi S; Sielaff T; Sherman CA; Batts KP Am J Surg Pathol; 2009 Jul; 33(7):963-75. PubMed ID: 18852678 [TBL] [Abstract][Full Text] [Related]
15. Hepatic structural dosimetry in (90)Y microsphere treatment: a Monte Carlo modeling approach based on lobular microanatomy. Gulec SA; Sztejnberg ML; Siegel JA; Jevremovic T; Stabin M J Nucl Med; 2010 Feb; 51(2):301-10. PubMed ID: 20080888 [TBL] [Abstract][Full Text] [Related]
16. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors. Sarfaraz M; Kennedy AS; Cao ZJ; Sackett GD; Yu CX; Lodge MA; Murthy R; Line BR; Van Echo DA Med Phys; 2003 Feb; 30(2):199-203. PubMed ID: 12607837 [TBL] [Abstract][Full Text] [Related]
17. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives]. Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591 [TBL] [Abstract][Full Text] [Related]
18. Posttherapy radiation safety considerations in radiomicrosphere treatment with 90Y-microspheres. Gulec SA; Siegel JA J Nucl Med; 2007 Dec; 48(12):2080-6. PubMed ID: 18006608 [TBL] [Abstract][Full Text] [Related]
19. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Kennedy AS; McNeillie P; Dezarn WA; Nutting C; Sangro B; Wertman D; Garafalo M; Liu D; Coldwell D; Savin M; Jakobs T; Rose S; Warner R; Carter D; Sapareto S; Nag S; Gulec S; Calkins A; Gates VL; Salem R Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1494-500. PubMed ID: 19157721 [TBL] [Abstract][Full Text] [Related]